Conti C R, Pepine C J, Feldman R L, Hill J A
Cardiology. 1985;72(5-6):297-321. doi: 10.1159/000173886.
At present nitrates remain the initial treatment for relief or prevention of angina in patients with coronary artery disease. In cases where nitrates and beta blockers have been used and are ineffective for managing effort angina, calcium antagonists may be substituted or added to the beta-blocking treatment. When the predominant symptom is rest angina, and there is evidence suggesting coronary artery spasm, nitrates and a calcium antagonist can be effective therapy. In patients with heart block, bradyarrhythmias, heart failure, or hypertension nifedipine may be the drug of choice. In contrast verapamil merits choice when supraventricular tachycardia is present. Diltiazem appears intermediate between nifedipine and verapamil and may be particularly useful when hypotension or other side effects must be avoided.
目前,硝酸盐类药物仍然是冠心病患者缓解或预防心绞痛的初始治疗药物。在使用硝酸盐类药物和β受体阻滞剂后仍无法有效控制劳力性心绞痛的情况下,可以用钙拮抗剂替代β受体阻滞剂治疗或在β受体阻滞剂治疗基础上加用钙拮抗剂。当主要症状为静息性心绞痛且有证据提示冠状动脉痉挛时,硝酸盐类药物和钙拮抗剂可能是有效的治疗方法。对于存在心脏传导阻滞、缓慢性心律失常、心力衰竭或高血压的患者,硝苯地平可能是首选药物。相比之下,当存在室上性心动过速时,维拉帕米更值得选用。地尔硫䓬的作用似乎介于硝苯地平和维拉帕米之间,当必须避免低血压或其他副作用时可能特别有用。